Helmut Schuhsler - Net Worth and Insider Trading

Helmut Schuhsler Net Worth

The estimated net worth of Helmut Schuhsler is at least $17 Million dollars as of 2024-11-10. Helmut Schuhsler is the Director, 10% Owner of Enanta Pharmaceuticals Inc and owns about 1,572,670 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $17 Million. Details can be seen in Helmut Schuhsler's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Helmut Schuhsler has not made any transactions after 2014-02-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Helmut Schuhsler

To

Helmut Schuhsler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Helmut Schuhsler owns 5 companies in total, including Acer Therapeutics Inc (ACER) , Protara Therapeutics Inc (TARA) , and Concert Pharmaceuticals Inc (CNCE) among others .

Click here to see the complete history of Helmut Schuhsler’s form 4 insider trades.

Insider Ownership Summary of Helmut Schuhsler

Ticker Comapny Transaction Date Type of Owner
ACER Acer Therapeutics Inc 2017-09-19 10 percent owner
TARA Protara Therapeutics Inc 2017-06-22 10 percent owner
CNCE Concert Pharmaceuticals Inc 2014-02-12 director & 10 percent owner
LIMIT LIMIT 2014-02-24 director & 10 percent owner
LIMIT LIMIT 2013-06-18 10 percent owner

Helmut Schuhsler Latest Holdings Summary

Helmut Schuhsler currently owns a total of 1 stock. Helmut Schuhsler owns 1,572,670 shares of Enanta Pharmaceuticals Inc (ENTA) as of February 24, 2014, with a value of $17 Million.

Latest Holdings of Helmut Schuhsler

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENTA Enanta Pharmaceuticals Inc 2014-02-24 1,572,670 11.07 17,409,457

Holding Weightings of Helmut Schuhsler


Helmut Schuhsler Form 4 Trading Tracker

According to the SEC Form 4 filings, Helmut Schuhsler has made a total of 0 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 60,477 shares on February 24, 2014, which brought Helmut Schuhsler around $2 Million.

Insider Trading History of Helmut Schuhsler

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Helmut Schuhsler Trading Performance

GuruFocus tracks the stock performance after each of Helmut Schuhsler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Helmut Schuhsler is 6.5%. GuruFocus also compares Helmut Schuhsler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Helmut Schuhsler within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Helmut Schuhsler's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Helmut Schuhsler

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 20.66 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 19.48 LIMIT LIMIT LIMIT LIMIT LIMIT

Helmut Schuhsler Ownership Network

Ownership Network List of Helmut Schuhsler

No Data

Ownership Network Relation of Helmut Schuhsler

Insider Network Chart

Helmut Schuhsler Owned Company Details

What does Acer Therapeutics Inc do?

Who are the key executives at Acer Therapeutics Inc?

Helmut Schuhsler is the 10 percent owner of Acer Therapeutics Inc. Other key executives at Acer Therapeutics Inc include director & President and Chief Executive Chris Schelling , Chief Operating Officer Tanya Hayden , and Chief Medical Officer Adrian W Quartel .

Acer Therapeutics Inc (ACER) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acer Therapeutics Inc (ACER) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acer Therapeutics Inc (ACER) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acer Therapeutics Inc (ACER)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acer Therapeutics Inc Insider Transactions

No Available Data

Helmut Schuhsler Mailing Address

Above is the net worth, insider trading, and ownership report for Helmut Schuhsler. You might contact Helmut Schuhsler via mailing address: C/o Tvm Techno Venture Management, Maximillianstr. 35, Entrace C D-, Munich 2m 80539.